[HTML][HTML] COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response
With a death toll of over one million worldwide, the COVID-19 pandemic caused by SARS-
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
[HTML][HTML] COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations
Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …
significantly higher than that of the first wave of early 2020. Many countries or regions have …
[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …
century. In 11 months since its first emergence, according to WHO, the causative infectious …
[HTML][HTML] From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
G Miao, Z Chen, H Cao, W Wu, X Chu, H Liu… - Biomedicine & …, 2023 - Elsevier
The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …
burden on healthcare systems and economies worldwide since the outbreak of the COVID …
COVID-19 vaccines: concerns beyond protective efficacy and safety
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
[HTML][HTML] Current status of COVID-19 vaccine development: focusing on antigen design and clinical trials on later stages
P Lee, CU Kim, SH Seo, DJ Kim - Immune network, 2021 - ncbi.nlm.nih.gov
The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human
health, economy, and social life worldwide. As a counteraction for this devastating disease …
health, economy, and social life worldwide. As a counteraction for this devastating disease …
[HTML][HTML] Counting on COVID-19 vaccine: insights into the current strategies, progress and future challenges
R Kandimalla, P Chakraborty, J Vallamkondu… - Biomedicines, 2021 - mdpi.com
The emergence of a novel coronavirus viz., severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in late 2019 and its subsequent substantial spread produced the …
2 (SARS-CoV-2) in late 2019 and its subsequent substantial spread produced the …
[HTML][HTML] A review of the safety and efficacy of current COVID-19 vaccines
Z Huang, Y Su, T Zhang, N Xia - Frontiers of Medicine, 2022 - Springer
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …
[HTML][HTML] The immunology of SARS-CoV-2 infections and vaccines
L Grigoryan, B Pulendran - Seminars in immunology, 2020 - Elsevier
Abstract SARS-CoV-2, the virus that causes COVID-19, emerged in late 2019, and was
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …
Promise and challenges in the development of COVID-19 vaccines
W Chen - Human Vaccines & Immunotherapeutics, 2020 - Taylor & Francis
The pandemic outbreak of COVID-19, caused by coronavirus SARS-CoV-2, created an
unprecedented challenge to global public health system and biomedical community …
unprecedented challenge to global public health system and biomedical community …